Acute renal failure due to continuous rifampicin

Area of Science:

• Nephrology
• Pharmacology
• Infectious Diseases

Background:

• Antituberculous therapy is crucial for managing tuberculosis.
• Rifampicin is a cornerstone antibiotic in first-line antituberculous regimens.
• Renal adverse events associated with rifampicin are uncommon but significant.

Observation:

• A patient developed acute renal failure during a standard course of daily antituberculous therapy.
• Renal biopsy confirmed interstitial nephritis as the pathological feature.
• Clinical and radiological findings normalized three weeks post-rifampicin cessation.

Findings:

• This case represents the fifth documented instance of renal impairment linked to continuous rifampicin use.
• The findings suggest a potential toxic interaction between rifampicin and other antituberculous drugs excreted renally.
• Interstitial nephritis is a possible mechanism for rifampicin-induced nephrotoxicity.

Implications:

• Clinicians should consider rifampicin as a potential cause of acute renal failure in patients undergoing antituberculous treatment.
• Monitoring renal function is advisable, especially in patients with co-administered renally excreted drugs.
• Further investigation into the pharmacokinetic and pharmacodynamic interactions of rifampicin is warranted.